BRCA1 mutations in South African breast and/or ovarian cancer families: Evidence of a novel founder mutation in Afrikaner families-Reference-Cited by-同舟云学术

BRCA1 mutations in South African breast and/or ovarian cancer families: Evidence of a novel founder mutation in Afrikaner families

Published:2004 Issue:5 Volume:110 Page:677-682
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Reeves Michelle D.,Yawitch Tali M.,van der Merwe Nerina C.,van den Berg Hester J.,Dreyer Greta,van Rensburg Elizabeth J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference56 articles.

1. Incidence of histologically diagnosed cancer in South Africa, 1993-1995. Johannesburg: National Cancer Registry of South Africa, South African Institute for Medical Research, 1998. 17 p

2. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

3. Identification of the breast cancer susceptibility gene BRCA2

4. Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

5. The Breast Cancer Information Core - database (Bic). http://www.nchgr.nih.gov/Intramural_research/ Lab_transfer/Bic

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients;Breast Cancer Research and Treatment;2024-05-30

2. Oncologic anthropology: Global variations in breast cancer risk, biology, and outcome;Journal of Surgical Oncology;2023-10-10

3. Breast Cancer Germline Genetic Counseling and Testing for Populations of African Heritage Globally: A Scoping Review on Research, Practice, and Bioethical Considerations;JCO Global Oncology;2023-09

4. The review of genetic screening services and common BRCA1/2 variants among South African breast cancer patients;Journal of Genetic Counseling;2023-08

5. A comprehensive survey on spectrum of BRCA1 and BRCA2 pathogenic variants in breast and ovarian cancer;Immunological Implications and Molecular Diagnostics of Genitourinary Cancer;2023